These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 21961327)

  • 21. [The efficacy of antioxidant therapy in patients with tuberculosis of the lungs and the correction of lipid peroxidation processes].
    Safarian MD; Karagezian KG; Karapetian ET; Avanesian NA
    Probl Tuberk; 1990; (5):40-4. PubMed ID: 2388892
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Combining antitubercular agents of similar hepatic toxicity].
    Niemirowska H; Pecyna-Sielewicz J; Styszewska H; Wareska W
    Gruzlica; 1975 Jan; 43(1):37-46. PubMed ID: 1110038
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effectiveness of intensive chemotherapy in combination with nonspecific pathogenetic agents in pulmonary tuberculosis].
    Batmanov NIa; Starostenko EV; Sanitskaia LN
    Probl Tuberk; 1979 Oct; (10):15-21. PubMed ID: 504102
    [No Abstract]   [Full Text] [Related]  

  • 24. [Use of cycloferon in the treatment of patients with pulmonary tuberculosis with mild clinical manifestations].
    Filippova TP; Vasil'eva LS; Kochkin AV
    Ter Arkh; 2010; 82(11):49-53. PubMed ID: 21381350
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immune modulatory and anti-oxidative effect of selenium against pulmonary tuberculosis.
    Hussain MI; Ahmed W; Nasir M; Mushtaq MH; Sheikh AA; Shaheen AY; Ali S; Iqbal S
    Pak J Pharm Sci; 2019 Mar; 32(2 (Supplementary)):779-784. PubMed ID: 31103972
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Modern aspects of the combined treatment of pulmonary tuberculosis in adolescents].
    Firsova VA; Rusakova LI; Gubkina MF; Ryzhova AP; Panova LV; Kobulashvili MG; Poluéktova FG; Iatskova TV
    Probl Tuberk; 2001; (7):21-3. PubMed ID: 11763555
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Exacerbation of pulmonary tuberculosis during chemotherapy].
    Karachunskii MA
    Probl Tuberk; 1996; (5):23-5. PubMed ID: 8984483
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of green tea extract (catechins) in reducing oxidative stress seen in patients of pulmonary tuberculosis on DOTS Cat I regimen.
    Agarwal A; Prasad R; Jain A
    Phytomedicine; 2010 Jan; 17(1):23-7. PubMed ID: 19910173
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Biochemical mechanisms of neurotoxic reactions to antibacterial preparations in patients with pulmonary tuberculosis].
    Chelnokova NV; Starostenko EV; Salpagarov AM; Smirnova NA; Kruglova EG
    Probl Tuberk; 1992; (1-2):8-10. PubMed ID: 1603797
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Theoretic principles of combined chemotherapy of tuberculosis: several viewpoints].
    Urbanczik R
    Prax Klin Pneumol; 1983 Sep; 37(9):380-4. PubMed ID: 6634640
    [No Abstract]   [Full Text] [Related]  

  • 31. [Current widely-used antitubercular chemotherapy regimens (report)].
    Anastasatu C; Bercea O; Gartner A
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1976; 25(2):85-91. PubMed ID: 181830
    [No Abstract]   [Full Text] [Related]  

  • 32. [Some regularities of an immune response in patients with pulmonary tuberculosis and drug-resistant Mycobacterium strains].
    Sakharova IIa; Ariél' BM; Knoring BE; Skvortsova LA; Vasil'eva GIu; Vishnevskiĭ BI; Pogodaeva SS
    Probl Tuberk Bolezn Legk; 2008; (12):22-7. PubMed ID: 19230184
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Organization and methods of correcting the chemotherapy of destructive pulmonary tuberculosis].
    Kovalenko NI; Ginzburg TS; Shapovalov VP; Taranenko MI
    Probl Tuberk; 1987; (9):35-8. PubMed ID: 3422965
    [No Abstract]   [Full Text] [Related]  

  • 34. [Erythrocyte metabolism during chemotherapy in pulmonary tuberculosis patients].
    Kaminskaia GO; Abdullaev RIu
    Probl Tuberk; 1993; (6):32-5. PubMed ID: 8290528
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Vitamin B complex metabolism in children with tuberculosis during combination vitamin therapy].
    Kirpichev MP
    Probl Tuberk; 1979 May; (5):48-53. PubMed ID: 314114
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical and laboratory studies in patients with pulmonary tuberculosis treated with pyrazinamide].
    Savula MM; Smolenko MI; Romaniuk MD; Slivka IuI
    Probl Tuberk; 1990; (11):25-8. PubMed ID: 2290809
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Remaxol restores the liver antioxidant protection system in experimental cyclophosphan-induced injury].
    Kovalenko AL; Petrov AIu; Sukhanov DS; Savateeva TN; Romantsov MG
    Eksp Klin Farmakol; 2011; 74(1):32-5. PubMed ID: 21476273
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical and epidemiological aspects of controlled short-term chemotherapy].
    Khomenko AG
    Probl Tuberk; 1998; (4):16-20. PubMed ID: 9771030
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemotherapy of tuberculosis for the 1980's.
    Dutt AK; Stead WW
    Clin Chest Med; 1980 May; 1(2):243-52. PubMed ID: 6794977
    [No Abstract]   [Full Text] [Related]  

  • 40. [Use of different regimes of etiopathogenetic therapy in pulmonary tuberculosis in adolescents].
    Pavlova MV
    Probl Tuberk; 1995; (5):30-2. PubMed ID: 7567888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.